pyruvate kinase PKLR isoform R-type (human)

A pyruvate kinase PKLR isoform R-type that is encoded in the genome of human.


polyembryoma of the ovary

biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:NamedThing biolink:ThingWithTaxon

A rare, malignant germ cell tumor arising from the ovary. It is characterized by the presence of embryoid bodies which resemble early embryos.


childhood ovarian yolk sac tumor

A yolk sac tumor that arises from the ovary and occurs in children.


ovarian yolk sac tumor

A usually rapidly growing malignant germ cell tumor arising from the ovary. It usually occurs in children and adolescents. Signs and symptoms include abdominal pain and a large abdominal or pelvic mass. The serum alpha-fetoprotein is almost always elevated preoperatively. Morphologically, there is marked heterogeneity due to numerous patterns of differentiation coexisting in the same tumor. The most common pattern is reticular.


gestational ovarian choriocarcinoma

A rare malignant trophoblastic tumor that arises from the ovary as a result of ectopic ovarian pregnancy. There is no germ cell component present.


ovarian yolk sac tumor, glandular pattern

A yolk sac tumor that arises from the ovary and is characterized by the presence of extensive differentiation into endodermal type glandular structures.


ovarian yolk sac tumor, hepatoid pattern

A yolk sac tumor that arises from the ovary and is characterized by the presence of extensive differentiation into hepatic tissue.


ovarian yolk sac tumor, polyvesicular vitelline pattern

A yolk sac tumor that arises from the ovary and is characterized by the presence of multiple dilated spaces lined by cells that resemble mesothelial cells. The dilated spaces coexist with columnar epithelial tissues.


childhood ovarian embryonal carcinoma

An embryonal carcinoma that arises from the ovary and occurs in children.


ovarian embryonal carcinoma

An embryonal carcinoma arising from the ovary. Signs and symptoms include the presence of an abdominal mass and abdominal pain.


threonine--tRNA ligase 1, cytoplasmic deaminated 1 (human)

A threonine--tRNA ligase 1, cytoplasmic (human) that has been deaminated on the residue at the position equivalent to Gln-111 of the amino acid sequence represented by UniProtKB:P26639-1. Example: UniProtKB:P26639-1, Gln-111, MOD:00685.


The (S)-enantiomer of 1-phenylethanamine.


sodium/potassium-transporting ATPase subunit beta-2 isoform 1 (human)

A sodium/potassium-transporting ATPase subunit beta-2 isoform 1 that is encoded in the genome of human.


platelet-derived growth factor receptor alpha sequence variant D846V, signal peptide removed phosphorylated 1 (human)

A platelet-derived growth factor receptor alpha (human) that has a Val residue at the position equivalent to Asp-846 of the amino acid sequence represented by UniProtKB:P16234-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-572, Tyr-574, Tyr-720, Tyr-731, Tyr-742, Tyr-754, Tyr-762, Tyr-768, Tyr-849, Tyr-988, and Tyr-1018. Example: UniProtKB:P16234-1, 24-1089, Tyr-572/Tyr-574/Tyr-720/Tyr-731/Tyr-742/Tyr-754/Tyr-762/Tyr-768/Tyr-849/Tyr-988/Tyr-1018, MOD:00048|Asp-846, CHEBI:30015.


tyrosine-protein phosphatase non-receptor type 2 isoform h1 (human)

A tyrosine-protein phosphatase non-receptor type 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P17706-1.


ferritin light chain deaminated 3 (human)

A ferritin light chain (human) that has been deaminated on the residue at the position equivalent to Asn-22 of the amino acid sequence represented by UniProtKB:P02792. UniProtKB:P02792, Asn-22, MOD:00684.


mast/stem cell growth factor receptor Kit sequence variant D419A, signal peptide removed phosphorylated 1 (human)

A mast/stem cell growth factor receptor Kit (human) that has an Ala residue at the position equivalent to Asp-419 of the amino acid sequence represented by UniProtKB:P10721-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-568, Tyr-570, Tyr-703, Tyr-721, Tyr-730, Tyr-823, and Tyr-936. Example: UniProtKB:P10721-1, 26-976, Asp-419, CHEBI:46217|Tyr-568/Tyr-570/Tyr-703/Tyr-721/Tyr-730/Tyr-823/Tyr-936, MOD:00048.


globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform h2 (human)

A globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N5D6-2.


globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform h3 (human)

A globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N5D6-3.


globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform 1 (human)

A globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform 1 that is encoded in the genome of human.


ferric-chelate reductase 1 O-glycosylated 1 (human)

A ferric-chelate reductase 1 (human) that has been O-glycosylated at the residue equivalent to Thr-182 of the amino acid sequence represented by UniProtKB:Q6ZNA5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q6ZNA5-1, Thr-182, MOD:00005~GNO:G43417UB.


BMP receptor type-2 sequence variant C118W (human)

A bone morphogenetic protein receptor type-2 (human) that has a Trp residue at the position equivalent to Cys-118 of the amino acid sequence represented by UniProtKB:Q13873-1. Example: UniProtKB:Q13873-1, Cys-118, CHEBI:29954.


NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 isoform h2 (human)

An NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O96000-2.


triacylglycerol 50:1

A triglyceride in which the three acyl groups contain a total of 50 carbons and 1 double bond.


albumin methylated 6 (human)

An albumin (human) that has been methylated on the residue at the position equivalent to Cys-485 of the amino acid sequence represented by UniProtKB:P02768-1. Example: UniProtKB:P02768-1, Cys-485, MOD:00660.


poly(A) RNA polymerase GLD2 isoform 1 (human)

A poly(A) RNA polymerase GLD2 isoform 1 that is encoded in the genome of human.


aldo-keto reductase family 1 member C3 cysteinylated 1 (human)

An aldo-keto reductase family 1 member C3 (human) that has been cysteinylated on the residue at the position equivalent to Cys-145 of the amino acid sequence represented by UniProtKB:P42330-1. Example: UniProtKB:P42330-1, Cys-145, MOD:00765.


aldo-keto reductase family 1 member C3

A protein that is a translation product of the human AKR1C3 gene or a 1:1 ortholog thereof.


aldo-keto reductase family 1 member C3 isoform h2 (human)

An aldo-keto reductase family 1 member C3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P42330-2.


aldo-keto reductase family 1 member C3 isoform h1 (human)

An aldo-keto reductase family 1 member C3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P42330-1.


Colforsin daropate hydrochloride

The hydrochloride salt of colforsin daropate. It is a drug used for the treatment of acute heart failure. It directly stimulates adenylate cyclase and produces positive inotropic and vasodilator effects accompanied by the increase in cellular cAMP.


formylthiophene

An aldehyde that is thiophene substituted by a formyl group at position 2.


mothers against decapentaplegic homolog 4 isoform 1 (human)

A smad4 isoform 1 that is encoded in the genome of human.


mothers against decapentaplegic homolog 4 isoform 1 monoubiquitinated 1 (human)

A smad4 isoform 1 monoubiquitinated 1 in human. UniProtKB:Q13485-1, Lys-507, MOD:01148.


mothers against decapentaplegic homolog 4 isoform 1 phosphorylated 1 (human)

A smad4 isoform 1 phosphorylated 1 in human. UniProtKB:Q13485-1, Thr-277, MOD:00047.


mothers against decapentaplegic homolog 4 isoform 1 monoubiquitinated 2 (human)

A smad4 isoform 1 monoubiquitinated 2 in human. UniProtKB:Q13485-1, Lys-519, MOD:01148.


kit ligand isoform 2 (rat)

A kit ligand isoform 2 that is encoded in the genome of rat.


ubiquitin carboxyl-terminal hydrolase 37 isoform h1 (human)

A ubiquitin carboxyl-terminal hydrolase 37 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86T82-1.


ubiquitin carboxyl-terminal hydrolase 37 isoform h2 (human)

A ubiquitin carboxyl-terminal hydrolase 37 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86T82-2.


ubiquitin carboxyl-terminal hydrolase 37 methylated 1 (human)

A ubiquitin carboxyl-terminal hydrolase 37 (human) that has been methylated on the residue at the position equivalent to Cys-473 of the amino acid sequence represented by UniProtKB:Q86T82-1. Example: UniProtKB:Q86T82-1, Cys-473, MOD:00660.


A oxysterol that is cholesterol in which the hydrogen at the 4beta position has been replaced by a hydroxy group. A metabolite of cholesterol formed by the drug-metabolizing enzyme cytochrome P450 3A4, it is one of the major oxysterols in the human circulation.


Stage I Ovarian Teratoma AJCC v6 and v7

Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both).  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th Eds.)


childhood immature teratoma of ovary

An immature teratoma that arises from the ovary and occurs in children.


Stage IV Ovarian Teratoma AJCC v6 and v7

Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)


immature ovarian teratoma

A malignant germ cell tumor arising from the ovary. It usually affects females in their first two decades of life. It contains variable amounts of immature embryonal tissues. Based on the amount of immature neuroepithelial component, immature teratomas are graded from 1 to 3. The stage and grade of the tumor and the grade of the metastatic tumor are the important factors that predict prognosis. The use of cisplatin-based combination chemotherapy has significantly improved the survival rates of the patients.


Stage III Ovarian Teratoma AJCC v6 and v7

Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)


Malignant Ovarian Teratoma

A teratoma that arises from the ovary. It is composed exclusively of immature tissue elements.


Stage II Ovarian Teratoma AJCC v6 and v7

Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)


intrinsic cardiomyopathy

A cardiomyopathy that is due to abnormalities in heart muscle cells.


glutaric acidemia IIc

Any multiple acyl-CoA dehydrogenase deficiency in which the cause of the disease is a mutation in the ETFDH gene.


familial cardiomyopathy

An instance of cardiomyopathy that is caused by an inherited modification of the individual's genome.


glutaric acidemia IIb

Any multiple acyl-CoA dehydrogenase deficiency in which the cause of the disease is a mutation in the ETFB gene.


familial hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy caused by mutations in the genes encoding components of the sarcomere, in the absence of predisposing conditions.


familial dilated cardiomyopathy

A a genetic form of heart disease that occurs when heart (cardiac) muscle becomes thin and weakened in at least one chamber of the heart, causing the open area of the chamber to become enlarged (dilated). As a result, the heart is unable to pump blood as efficiently as usual. To compensate, the heart attempts to increase the amount of blood being pumped through the heart, leading to further thinning and weakening of the cardiac muscle. Over time, this condition results in heart failure.


multiple acyl-CoA dehydrogenase deficiency, severe neonatal type


glutaric acidemia IIa

Any multiple acyl-CoA dehydrogenase deficiency in which the cause of the disease is a mutation in the ETFA gene.


multiple acyl-CoA dehydrogenase deficiency, mild type


RNA-binding protein EWS isoform EWS (human)

An RNA-binding protein EWS (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q01844-1.


alpha-2-HS-glycoprotein N-glycosylated 28 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G94917XT.


A protein that is a translation product of the human AHSG gene or a 1:1 ortholog thereof.


alpha-2-HS-glycoprotein O-glycosylated 24 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G43417UB.


alpha-2-HS-glycoprotein O-glycosylated 22 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G17015OC.


alpha-2-HS-glycoprotein N-glycosylated 14 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G95865ZB. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G95865ZB.


alpha-2-HS-glycoprotein O-glycosylated 20 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-197 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Thr-197, MOD:00005~GNO:G43417UB.


alpha-2-HS-glycoprotein N-glycosylated 1 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G00912UN.


alpha-2-HS-glycoprotein O-glycosylated 8 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G53434XO.


alpha-2-HS-glycoprotein N-glycosylated 4 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G10486CT.


alpha-2-HS-glycoprotein acetylated 1 (human)

An alpha-2-HS-glycoprotein (human) that has been acetylated on the residue at the position equivalent to Lys-218 of the amino acid sequence represented by UniProtKB:P02765. UniProtKB:P02765, Lys-218, MOD:00723.


alpha-2-HS-glycoprotein O-glycosylated 15 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G17015OC.


alpha-2-HS-glycoprotein N-glycosylated 2 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G06247RL.


alpha-2-HS-glycoprotein N-glycosylated 9 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G59626AS.


alpha-2-HS-glycoprotein O-glycosylated 9 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-293 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-293, MOD:00002~GNO:G29068FM.


alpha-2-HS-glycoprotein N-glycosylated 3 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G08293MJ.


alpha-2-HS-glycoprotein O-glycosylated 18 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G59626AS.


alpha-2-HS-glycoprotein O-glycosylated 13 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-328 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-328, MOD:00002~GNO:G29068FM.


alpha-2-HS-glycoprotein N-glycosylated 20 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G27947YN.


alpha-2-HS-glycoprotein O-glycosylated 5 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G29068FM.


alpha-2-HS-glycoprotein O-glycosylated 23 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G23729WG. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G23729WG.


alpha-2-HS-glycoprotein N-glycosylated 19 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G22140GZ.


alpha-2-HS-glycoprotein O-glycosylated 10 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-293 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-293, MOD:00002~GNO:G43417UB.


alpha-2-HS-glycoprotein O-glycosylated 21 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-202 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Thr-202, MOD:00005~GNO:G43417UB.


alpha-2-HS-glycoprotein N-glycosylated 27 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G88374WZ.


alpha-2-HS-glycoprotein N-glycosylated 8 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G40926MX.


alpha-2-HS-glycoprotein methylated 1 (human)

An alpha-2-HS-glycoprotein (human) that has been methylated on the residue at the position equivalent to Cys-219 of the amino acid sequence represented by UniProtKB:P02765. UniProtKB:P02765, Cys-219, MOD:00660.


alpha-2-HS-glycoprotein N-glycosylated 22 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G36131WL. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G36131WL.


alpha-2-HS-glycoprotein N-glycosylated 11 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G85144OK.


alpha-2-HS-glycoprotein O-glycosylated 7 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G43417UB.


alpha-2-HS-glycoprotein O-glycosylated 16 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G29068FM.


alpha-2-HS-glycoprotein O-glycosylated 1 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-196 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-196, MOD:00002~GNO:G43417UB.


alpha-2-HS-glycoprotein O-glycosylated 25 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G65562ZE.


alpha-2-HS-glycoprotein O-glycosylated 12 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-325 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-325, MOD:00002~GNO:G43417UB.


alpha-2-HS-glycoprotein N-glycosylated 18 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G10486CT.


alpha-2-HS-glycoprotein N-glycosylated 10 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G84467IZ.


alpha-2-HS-glycoprotein O-glycosylated 3 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-256 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02765-1, Ser-256, MOD:00002~GNO:G65562ZE.


alpha-2-HS-glycoprotein N-glycosylated 17 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G08293MJ.


alpha-2-HS-glycoprotein N-glycosylated 23 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G54992WG. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G54992WG.


alpha-2-HS-glycoprotein N-glycosylated 26 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G85144OK.


alpha-2-HS-glycoprotein N-glycosylated 5 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G22140GZ.


alpha-2-HS-glycoprotein O-glycosylated 6 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G40740AD. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G40740AD.


alpha-2-HS-glycoprotein O-glycosylated 14 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-328 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-328, MOD:00002~GNO:G43417UB.


alpha-2-HS-glycoprotein O-glycosylated 17 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G43417UB.


alpha-2-HS-glycoprotein N-glycosylated 16 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G06247RL.


alpha-2-HS-glycoprotein N-glycosylated 25 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G84467IZ.


alpha-2-HS-glycoprotein O-glycosylated 2 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-256 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P02765-1, Ser-256, MOD:00002~GNO:G17015OC.


alpha-2-HS-glycoprotein N-glycosylated 24 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G59626AS.


alpha-2-HS-glycoprotein O-glycosylated 4 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G27391WQ. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G27391WQ.


alpha-2-HS-glycoprotein N-glycosylated 15 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G00912UN.


alpha-2-HS-glycoprotein O-glycosylated 19 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G65562ZE.


alpha-2-HS-glycoprotein phosphorylated 1 (human)

An alpha-2-HS-glycoprotein (human) that has been phosphorylated on the residue at the position equivalent to Ser-138 of the amino acid sequence represented by UniProtKB:P02765. UniProtKB:P02765, Ser-138, MOD:00046.


alpha-2-HS-glycoprotein N-glycosylated 21 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G29068FM.


alpha-2-HS-glycoprotein N-glycosylated 13 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G94917XT.


alpha-2-HS-glycoprotein N-glycosylated 12 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G88374WZ.


alpha-2-HS-glycoprotein O-glycosylated 11 (human)

An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-325 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-325, MOD:00002~GNO:G29068FM.


alpha-2-HS-glycoprotein N-glycosylated 6 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G27947YN.


alpha-2-HS-glycoprotein N-glycosylated 7 (human)

An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G36131WL. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G36131WL.


myotubularin-related protein 6 methylated 1 (human)

A myotubularin-related protein 6 (human) that has been methylated on the residue at the position equivalent to Cys-88 of the amino acid sequence represented by UniProtKB:Q9Y217-1. Example: UniProtKB:Q9Y217-1, Cys-88, MOD:00660.


DNA-directed RNA polymerase II subunit RPB7 methylated 1 (human)

A DNA-directed RNA polymerase II subunit RPB7 (human) that has been methylated on the residue at the position equivalent to Cys-38 of the amino acid sequence represented by UniProtKB:P62487. UniProtKB:P62487, Cys-38, MOD:00660.


DNA-directed RNA polymerase II subunit RPB7 glutathionylated 1 (human)

A DNA-directed RNA polymerase II subunit RPB7 (human) that has been glutathionylated on the residue at the position equivalent to Cys-127 of the amino acid sequence represented by UniProtKB:P62487. UniProtKB:P62487, Cys-127, MOD:00234.


DNA-directed RNA polymerase II subunit RPB7 isoform 1 (human)

A DNA-directed RNA polymerase II subunit RPB7 isoform 1 that is encoded in the genome of human.


DNA-directed RNA polymerase II subunit RPB7 cysteinylated 1 (human)

A DNA-directed RNA polymerase II subunit RPB7 (human) that has been cysteinylated on the residue at the position equivalent to Cys-38 of the amino acid sequence represented by UniProtKB:P62487. UniProtKB:P62487, Cys-38, MOD:00765.


DNA-directed RNA polymerase II subunit RPB7 methylated 2 (human)

A DNA-directed RNA polymerase II subunit RPB7 (human) that has been methylated on the residue at the position equivalent to Cys-106 of the amino acid sequence represented by UniProtKB:P62487. UniProtKB:P62487, Cys-106, MOD:00660.


O-phospho-D-serine

The D-enantiomer of O-phosphoserine.


1alpha,25-dihydroxy-26,27-dimethyl-22-oxavitamin D3 / 1alpha,25-dihydroxy-26,27-dimethyl-22-oxacholecalciferol


Poly-L-lysine (n > 40) in which 50-70% of the epsilon-amino groups are substituted with benzylpenicilloyl groups. It is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy.


thiazolidinemonocarboxylic acid

A thiazolidine or thiazolidine derivative carrying a single carboxy substituent.


L-thioproline

An optically active version of thioproline having L-configuration.


benzylpenicilloyl-butylamine

An amide formed between benzylpenicillin and butylamine.


An amide formed between 6-aminopenicillin and butylamine.


thiazolidine-2-carboxylic acid

A thiazolidinemonocarboxylic acid that is 1,3-thiazolidine substituted by a carboxy group at position 2.


letosteine

A  dicarboxylic acid monoester that is the monoethyl ester of 2-{2-[(carboxymethyl)sulfanyl]ethyl}-1,3-thiazolidine-4-carboxylic acid. A mucolytic used in the treatment of chronic bronchopneumopathies and related conditions.


ampicilloyl-butylamine

An amide formed between ampicillin and butylamine.


A thiazolidinemonocarboxylic acid  that is L-thioproline with a sulfomethyl group at position 2.


thioproline

A sulfur-containing amino acid that is proline in which the methylene group at position 4 is replaced by a sulfur atom.


amoxicilloyl-benzylamine

Amide formed between amoxicillin and benzylamine.


Amide formed between 6-aminopenicillanic acid and benzylamine.


Axo-pll

Poly-L-lysine (n > 40) in which 50-70% of the epsilon-amino groups are substituted with amoxicilloyl groups.


D-thioproline

An optically active version of thioproline having D-configuration.


raphanusamic acid

A thiazolidinemonocarboxylic acid that is 2-thioxo-1,3-thiazolidine with the carboxy group located at position 4 (the R-enantiomer).


amoxicilloic acid

A  thiazolidinemonocarboxylic acid obtained via hydrolysis of the beta-lactam ring of amoxicillin.


N,S-isopropylidene-D-penicillamine

A thiazolidinemonocarboxylic acid having the carboxy group at the 4-position and four additional methyl substituents at positions 2, 2, 5 and 5.


amoxicillin diketopiperazine

A member of the class of 2,5-diketopiperazines obtained via autoaminolysis of amoxicillin.


A thiazolidinemonocarboxylic acid that is  1,3-thiazolidine substituted by geminal methyl groups at position 2 and a carboxy group at position 4 (the 4R stereoisomer).


benzylpenilloic acid

A thiazolidinemonocarboxylic acid resulting from nucleophilic cleavage of the beta-lactam ring of benzylpenicillin.


amoxicilloyl-butylamine

A monocarboxylic acid amide formed by nucleophilic ring cleavage of the beta-lactam ring of amoxicillin by butylamine.


CCA tRNA nucleotidyltransferase 1, mitochondrial isoform 1 (human)

A CCA tRNA nucleotidyltransferase 1, mitochondrial isoform 1 that is encoded in the genome of human.


serine/threonine-protein kinase receptor R3 sequence variant F425del (human)

A serine/threonine-protein kinase receptor R3 (human) that has a single-residue deletion at the position equivalent to Phe-425 of the amino acid sequence represented by UniProtKB:P37023. UniProtKB:P37023, 22-423, 425-503.


nuclear factor of activated T-cells, cytoplasmic 1 phosphorylated 2 (human)

A nuclear factor of activated T-cells, cytoplasmic 1 (human) that has been post-translationally modified to include phosphoserine at positions 175, 176, 178, 179, 181, 233, 237, 241, 257, 278, 286 and 290 of the amino acid sequence represented by UniProtKB:O95644. UniProtKB:O95644, Ser-175/Ser-176/Ser-178/Ser-179/Ser-181/Ser-233/Ser-237/Ser-241/Ser-257/Ser-278/Ser-286/Ser-290, MOD:00046.


lateral signaling target protein 2 homolog isoform h6 (human)

A lateral signaling target protein 2 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9HCC9-6.


A 3-oxo-5beta-steroid that is 5beta-cholestan-3-one bearing two additional hydroxy substituents at positions 7alpha and 12alpha.


myosin-IIIb isoform h2 (human)

A myosin-IIIb (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WXR4-2.


ATP-binding cassette sub-family C member 2 sequence variant I1173F (human)

An ATP-binding cassette sub-family C member 2 (human) that has a Phe residue at the position equivalent to Ile-1173 of the amino acid sequence represented by UniProtKB:Q92887. UniProtKB:Q92887, Ile-1173, CHEBI:29997.


ATP-binding cassette sub-family C member 2 sequence variant R1150H (human)

An ATP-binding cassette sub-family C member 2 (human) that has a His residue at the position equivalent to Arg-1150 of the amino acid sequence represented by UniProtKB:Q92887. UniProtKB:Q92887, Arg-1150, CHEBI:29979.


ATP-binding cassette sub-family C member 2 phosphorylated 1 (human)

An ATP-binding cassette sub-family C member 2 (human) that has been phosphorylated on the residue at the position equivalent to Thr-902 of the amino acid sequence represented by UniProtKB:Q92887. UniProtKB:Q92887, Thr-902, MOD:00047.


ATP-binding cassette sub-family C member 2 cysteinylated 1 (human)

An ATP-binding cassette sub-family C member 2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-544 of the amino acid sequence represented by UniProtKB:Q92887. UniProtKB:Q92887, Cys-544, MOD:00765.


ATP-binding cassette sub-family C member 2 sequence variant R768W (human)

An ATP-binding cassette sub-family C member 2 (human) that has a Trp residue at the position equivalent to Arg-768 of the amino acid sequence represented by UniProtKB:Q92887. UniProtKB:Q92887, Arg-768, CHEBI:29954.


lanosterol 14-alpha demethylase isoform 1 (human)

A lanosterol 14-alpha demethylase isoform 1 that is encoded in the genome of human.


adenosine 3'-phospho 5'-phosphosulfate transporter 1 isoform h4 (human)

An adenosine 3'-phospho 5'-phosphosulfate transporter 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TB61-4.


UDP-glucose 4-epimerase isoform h2 (human)

A UDP-glucose 4-epimerase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14376-2.


UDP-glucose 4-epimerase isoform h1 (human)

A UDP-glucose 4-epimerase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14376-1.


UDP-glucose 4-epimerase sequence variant V94M (human)

A UDP-glucose 4-epimerase (human) that has a Met residue at the position equivalent to Val-94 of the amino acid sequence represented by UniProtKB:Q14376-1. Example: UniProtKB:Q14376-1, Val-94, CHEBI:16044.


serine/threonine-protein kinase PAK 6

A protein that is a translation product of the human PAK6 gene or a 1:1 ortholog thereof.


serine/threonine-protein kinase PAK 6 isoform 1 (human)

A serine/threonine-protein kinase PAK 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NQU5-1.


serine/threonine-protein kinase PAK 6 isoform h2 (human)

A serine/threonine-protein kinase PAK 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NQU5-2.


haptoglobin N-glycosylated 41 (human)

A haptoglobin (human) that has been N-glycosylated at the residue equivalent to Asn-211 of the amino acid sequence represented by UniProtKB:P00738-1, in which the glycan structure is represented by GlyTouCan:G62165AG. Example: UniProtKB:P00738-1, Asn-211, MOD:00160~GNO:G62165AG.


ADP-ribosylation factor 6

A protein that is a translation product of the human ARF6 gene or a 1:1 ortholog thereof.


ADP-ribosylation factor 6, initiator methionine removed form (human)

An ADP-ribosylation factor 6 (human) that has had the initiator methionine removed. UniProtKB:P62330, 2-175.


ADP-ribosylation factor 6 isoform 1 (human)

An ADP-ribosylation factor 6 isoform 1 that is encoded in the genome of human.


cell cycle control protein 50A deaminated 4 (human)

A cell cycle control protein 50A (human) that has been deaminated on the residue at the position equivalent to Asn-347 of the amino acid sequence represented by UniProtKB:Q9NV96-1. Example: UniProtKB:Q9NV96-1, Asn-347, MOD:00684.


acid-sensing ion channel 1 isoform h1 (human)

An acid-sensing ion channel 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P78348-1.


phosphatidylserine synthase 2

A protein that is a translation product of the human PTDSS2 gene or a 1:1 ortholog thereof.


PR domain zinc finger protein 2 isoform h2 (human)

A PR domain zinc finger protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13029-2.


saturated fatty acid

Any fatty acid containing no carbon to carbon multiple bonds. Known to produce adverse biological effects when ingested to excess.


A 1-acyl-2-alkyl-sn-glycero-3-phosphocholine in which the acyl and alkyl groups at posiitons 1 and 2 are specified respectively as hexadecanoyl and methyl.


branched-chain saturated fatty acid

Any saturated fatty acid with a carbon side-chain or isopropyl termination.


(R)-2-methylbutyric acid

The (R)-enantiomer of 2-methylbutanoic acid.


methylbutyric acid

A methyl-branched fatty acid comprising a butyric acid core carrying a single methyl substituent.


(2R,6S,10S)-2,6,10,14-pristanic acid

The (2R,6S,10S)-diastereomer of pristanic acid.


straight-chain saturated fatty acid

Any saturated fatty acid lacking a side-chain.


protein kinase C delta type phosphorylated 2 (human)

A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Thr-507 of the amino acid sequence represented by UniProtKB:Q05655. UniProtKB:Q05655, Thr-507, MOD:00047.


protein kinase C delta type

A protein kinase C, delta-like that is a translation product of the human PRKCD gene or a 1:1 ortholog thereof.


protein kinase C delta type deaminated 1 (human)

A protein kinase C delta type (human) that has been deaminated on the residue at the position equivalent to Asn-407 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Asn-407, MOD:00684.


protein kinase C delta type phosphorylated 3 (human)

A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Thr-507, and phosphoserine at positions 645 and 664 of the amino acid sequence represented by UniProtKB:Q05655. UniProtKB:Q05655, Thr-507, MOD:00047|Ser-645/Ser-664, MOD:00046.


protein kinase C delta type phosphorylated 5 (human)

A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Ser-359 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Ser-359, MOD:00046.


protein kinase C delta type methylated 2 (human)

A protein kinase C delta type (human) that has been methylated on the residue at the position equivalent to Cys-415 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Cys-415, MOD:00660.


protein kinase C delta type phosphorylated 6 (human)

A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Thr-85 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Thr-85, MOD:00047.


protein kinase C delta type isoform h2 (human)

A protein kinase C delta type (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q05655-2.


protein kinase C delta type phosphorylated 4 (human)

A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Ser-645 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Ser-645, MOD:00046.


protein kinase C delta type phosphorylated 1 (human)

A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Tyr-155 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Tyr-155, MOD:00048.


protein kinase C delta type methylated 1 (human)

A protein kinase C delta type (human) that has been methylated on the residue at the position equivalent to Cys-175 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Cys-175, MOD:00660.


protein kinase C delta type isoform 1 (human)

A protein kinase C delta type isoform 1 that is encoded in the genome of human.


basement membrane-specific heparan sulfate proteoglycan core protein O-glycosylated 29 (human)

A basement membrane-specific heparan sulfate proteoglycan core protein (human) that has been O-glycosylated at the residue equivalent to Thr-1876 of the amino acid sequence represented by UniProtKB:P98160-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P98160-1, Thr-1876, MOD:00005~GNO:G43417UB.


guanylate cyclase soluble subunit alpha-1 phosphorylated 1 (human)

A guanylate cyclase soluble subunit alpha-1 (human) that has been phosphorylated on the residue at the position equivalent to Thr-285 of the amino acid sequence represented by UniProtKB:Q02108-1. Example: UniProtKB:Q02108-1, Thr-285, MOD:00047.


bryotoxin A

A bufadienolide glycoside that is 3,5,11,14-tetrahydroxy-12,19-dioxobufa-20,22-dienolide attached to a 3-O-acetyl-4,6-dideoxy-beta-D-arabino-hexopyranosyl residue at position 3 via a glycosidic linkage.


An  ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3 and 5 and a methoxy group at position 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from Aspergillus ochraceus.


A 3beta-hydroxy steroid consisting of 23,24-dimethylcholest-16-ene substituted by hydroxy groups at positions 3, 5, 6 and 20 (the 3beta,5alpha,6beta,20S stereoisomer). Isolated from the soft coral Sarcophyton trocheliophorum, it exhibits cytotoxic activity against human cancer cells.


cerevisterol

An ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the fungus, Xylaria species.


eurysterol B sulfonic acid

A steroid sulfate that is 5alpha-cholestane with a double bond at position 22, hydroxy groups at positions 5 and 6, a bridged oxolane between positions 8 and 19 and a sulfate group at position 3.


blazein

An ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3 and 5 and a methoxy group at position 6 (the 3beta,5alpha stereoisomer). It has been isolated from the fungus, Xylaria species.


erysimoside

A cardenolide glycoside that consists of strophanthidin having a beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl moiety attached at position 3.


lucibufagin C

A defensive steroid lactone that is produced by males of the species Photinus pyralis.


helveticoside

A cardenolide glycoside that consists of strophanthidin having a digitoxosyl group attached at position 3.


globosterol

A 3beta-sterol that is 5alpha-androstane which contains a double bond between positions 7 and 8, in which the hydrogens at the 3beta, 5alpha and 6beta positions are substituted by hydroxy groups, and in which the hydrogen at the 17beta position is substituted by a (2S,3E,6xi)-6,7-dimethyloct-3-en-2-yl group. The polyhydroxylated C29 sterol was isolated from an endophytic fungus, Chaetomium globosum ZY-22; the stereochemistry at position 25 was not determined.


eurysterol A sulfonic acid

A steroid sulfate that is 5alpha-cholestane substituted by hydroxy groups at positions 5 and 6, a bridged oxolane at positions 8 and 19 pand a sulfate group at position 3.


An ergostanoid that is (22E)-ergosta-7,22-diene substituted by beta-hydroxy groups at positions 3 and 6. It has been isolated from Aspergillus ochraceus.


A 3beta-sterol that is ergosta-7,22-dien-3-ol substituted by additional hydroxy groups at positions 5, 6 and 9 (3beta,5alpha,6beta,22E stereoisomer). It has been isolated from the endophytic fungus, Chaetomium globosum.


A withanolide that is 3,6:22,26-diepoxyergost-24-ene substituted by hydroxy groups at positions 4, 5 and 27 and oxo groups at positions 1 and 26. It has been isolated from the aerial parts of Physalis longifolia.


convallatoxin

A cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3.


An  ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at position 3 and 5 and an oxo group at position 6 (the 3beta,5alpha stereoisomer). It has been isolated from Aspergillus ochraceus.


An ergostanoid that is  (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3, 5 and 9 and an oxo group at position 6 (the 3beta,5alpha stereoisomer). It has been isolated from Aspergillus ochraceus.


dihydroouabagenin

A hexahydroxy steroidal lactone that is the 20,22-dihydro derivative of ouabagenin.


A  3beta-hydroxy steroid that is  stigmastane substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the roots of Breynia fruticosa.


A cardenolide glycoside that is strophanthidin attached to a 4,6-dideoxy-3-O-(beta-D-glucopyranosyl)-2-O-methyl-beta-D-xylo-hexopyranosyl residue at position 3 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits cytotoxic activity.


ouabagenin

A hexahydroxy steroidal lactone obtained by hydrolysis of ouabain.


physalin D

A physalin with antimalarial and antimycobacterial activities isolated from Physalis angulata.


copper transport protein ATOX1 methylated 1 (human)

A copper transport protein ATOX1 (human) that has been methylated on the residue at the position equivalent to Cys-41 of the amino acid sequence represented by UniProtKB:O00244. UniProtKB:O00244, Cys-41, MOD:00660.


copper transport protein ATOX1

A protein that is a translation product of the human ATOX1 gene or a 1:1 ortholog thereof.


copper transport protein ATOX1 cysteinylated 1 (human)

A copper transport protein ATOX1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-15 of the amino acid sequence represented by UniProtKB:O00244. UniProtKB:O00244, Cys-15, MOD:00765.


copper transport protein ATOX1 isoform 1 (human)

A copper transport protein ATOX1 isoform 1 that is encoded in the genome of human.


farnesol

A farnesane sesquiterpenoid that is dodeca-2,6,10-triene substituted by methyl groups at positions 3, 7 and 11 and a hydroxy group at position 1.


immunoglobulin heavy constant mu N-glycosylated 96 (human)

An immunoglobulin heavy constant mu (human) that has been N-glycosylated at the residue equivalent to Asn-46 of the amino acid sequence represented by UniProtKB:P01871-2, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P01871-2, Asn-46, MOD:00160~GNO:G12580WI.


DNA ligase 1 isoform h2 (human)

A DNA ligase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P18858-2.


Stage IA2 Lung Cancer AJCC v8

Stage IA2 includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.)


electrogenic sodium bicarbonate cotransporter 1 sequence variant G427L (human)

An electrogenic sodium bicarbonate cotransporter 1 (human) that has a Leu residue at the position equivalent to Gly-427 of the amino acid sequence represented by UniProtKB:Q9Y6R1-1. Example: UniProtKB:Q9Y6R1-1, Gly-427, CHEBI:30006.


O-hexadecanedioyl-L-carnitine

An O-acyl-L-carnitine in which the acyl group is specified as hexadecanedioyl.


tyrosine-protein phosphatase non-receptor type 1 methylated 2 (human)

A tyrosine-protein phosphatase non-receptor type 1 (human) that has been methylated on the residue at the position equivalent to Cys-121 of the amino acid sequence represented by UniProtKB:P18031. UniProtKB:P18031, Cys-121, MOD:00660.


tyrosine-protein phosphatase non-receptor type 1 phosphorylated 1 (human)

A tyrosine-protein phosphatase non-receptor type 1 (human) that has been phosphorylated at Tyr-66. UniProtKB:P18031, Tyr-66, MOD:00048.


tyrosine-protein phosphatase non-receptor type 1 methylated 1 (human)

A tyrosine-protein phosphatase non-receptor type 1 (human) that has been methylated on the residue at the position equivalent to Cys-426 of the amino acid sequence represented by UniProtKB:P18031. UniProtKB:P18031, Cys-426, MOD:00660.


ectonucleotide pyrophosphatase/phosphodiesterase family member 2 isoform h2 (human)

An ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13822-2.


citramalyl-CoA lyase, mitochondrial

A protein that is a translation product of the human CLYBL gene or a 1:1 ortholog thereof.


citramalyl-CoA lyase, mitochondrial isoform h1 (human)

A citramalyl-CoA lyase, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N0X4-1.


citramalyl-CoA lyase, mitochondrial isoform h2 (human)

A citramalyl-CoA lyase, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N0X4-2.


phospholipid-transporting ATPase ABCA7 isoform h1 (human)

A phospholipid-transporting ATPase ABCA7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IZY2-1.


cytochrome b-c1 complex subunit 6, mitochondrial cysteinylated 2 (human)

A cytochrome b-c1 complex subunit 6, mitochondrial (human) that has been cysteinylated on the residue at the position equivalent to Cys-37 of the amino acid sequence represented by UniProtKB:P07919. UniProtKB:P07919, Cys-37, MOD:00765.


ornithine decarboxylase antizyme 2 isoform 1 (human)

An ornithine decarboxylase antizyme 2 isoform 1 that is encoded in the genome of human.


ubiquitin/ISG15-conjugating enzyme E2 L6 isoform 1 (human)

A ubiquitin/ISG15-conjugating enzyme E2 L6 isoform 1 that is encoded in the genome of human.


calcium-dependent secretion activator 2 isoform h1 (human)

A calcium-dependent secretion activator 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86UW7-1.


ectonucleoside triphosphate diphosphohydrolase 3 isoform h2 (human)

An ectonucleoside triphosphate diphosphohydrolase 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75355-2.


cadherin-5 N-glycosylated 2 (human)

A cadherin-5 (human) that has been N-glycosylated at the residue equivalent to Asn-442 of the amino acid sequence represented by UniProtKB:P33151-1, in which the glycan composition is represented by GlyTouCan:G80475RE. Example: UniProtKB:P33151-1, Asn-442, MOD:00160~GNO:G80475RE.


cAMP-dependent protein kinase inhibitor gamma isoform 1 (human)

A cAMP-dependent protein kinase inhibitor gamma isoform 1 that is encoded in the genome of human.


Lung Carcinoma Metastatic in the Bone

A carcinoma that arises from the lung and has metastasized to the bone.


syndromic disease

A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.


autoinflammatory syndrome

A group of disorders of the innate immune system characterized by attacks of seemingly unprovoked inflammation without significant levels of either autoantibodies or autoreactive T cells more characteristic of autoimmune disease.


Felty syndrome

Felty syndrome (FS), also known as ''super rheumatoid'' disease, is a severe form of rheumatoid arthritis (RA), characterized by a triad of RA, splenomegaly and neutropenia, resulting in susceptibility to bacterial infections.


Hereditary paraganglioma-pheochromocytomas (PGL/PCC) are rare neuroendocrine tumors represented by paragangliomas (occurring in any paraganglia from the skull base to the pelvic floor) and pheochromocytomas (adrenal medullary paragangliomas).


triple-A syndrome

Triple A syndrome is a very rare multisystem disease characterized by adrenal insufficiency with isolated glucocorticoid deficiency, achalasia, alacrima, autonomic dysfunction and neurodegeneration.


neoplastic syndrome

A broad classification for disorders in which the development of neoplasms typically occur in association with a characteristic set of signs or symptoms. These disorders may be inherited or acquired.


Crigler-Najjar syndrome

Crigler-Najjar syndrome (CNS) is a hereditary disorder of bilirubin metabolism characterized by unconjugated hyperbilirubinemia due to a hepatic deficit of bilirubin glucuronosyltransferase (GT) activity. Two types have been described, CNS types 1 and 2. CNS1 is characterized by a complete deficit of the enzyme and is unaffected by phenobarbital induction therapy, whereas the enzymatic deficit is partial and responds to phenobarbital in CNS2.


Guillain-Barre syndrome

A spectrum of rare post-infectious neuropathies that usually occur in otherwise healthy patients. GBS is clinically heterogeneous and encompasses acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN), Miller-Fisher syndrome (MFS) and some other regional variants.


periodic fever syndrome

Fevers of unknown etiology recurring over months or years.


telomere syndrome

Accelerated aging syndromes often caused by inheritable gene mutations resulting in decreased telomere lengths.


mucopolysaccharidosis type 4

Mucopolysaccharidosis type IV (MPS IV) is a lysosomal storage disease belonging to the group of mucopolysaccharidoses, and characterized by spondylo-epiphyso-metaphyseal dysplasia. It exists in two forms, A and B.


congenital T-cell immunodeficiency

A broad classification of inherited disorders presenting at birth that affect the cell-mediated aspect of the immune response. Circulating numbers of T lymphocytes are decreased or ineffective.


Zellweger spectrum disorders

The most severe variant seen in the peroxisome biogenesis disorders that is characterized by neuronal migration defects in the brain, dysmorphic craniofacial features, profound hypotonia, neonatal seizures, and liver dysfunction.


abdominal obesity-metabolic syndrome

A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance.


Neoplastic Syndromes, Hereditary

An inherited genetic condition in which members within a family are at an increased risk for the development of benign and/or malignant neoplasms.


Bartter syndrome

Bartter syndrome is a group of rare renal tubular disease characterized by impaired salt reabsorption in the thick ascending limb of Henle's loop and clinically by the association of hypokalemic alkalosis, hypercalciuria/nephrocalcinosis, increased levels of plasma renin and aldosterone, low blood pressure and vascular resistance to angiotensin II.


T-cell immunodeficiency

A broad classification of disorders that affect the cell-mediated aspect of the immune response. Circulating numbers of T lymphocytes are decreased or ineffective.


Wolfram syndrome

Wolfram syndrome (WS) also known as DIDMOAD, is a neurodegenerative disorder characterized by type I diabetes mellitus (DM), diabetes insipidus (DI), sensorineural deafness (D), bilateral optical atrophy (OA) and neurological signs. Other related problems are urinary tract atony, ataxia, peripheral neuropathy, psychiatric disorders and/or seizures. 2 types of WS may be distinguished: type 1 and type 2 (WS1 and WS2).


overgrowth syndrome

A group of syndromes caused by genetic birth defects that may lead to the development of malignancies. It is characterized by a large body size or large body parts at birth, or excessive body growth early in childhood. Representative examples include neurofibromatosis, Beckwith-Wiedemann syndrome, and Sturge-Weber syndrome.


developmental defect during embryogenesis

A disease that has its basis in the disruption of embryonic morphogenesis.


Rare Neoplastic Syndrome

A broad classification for uncommon disorders in which the development of neoplasms occur in association with a characteristic set of signs or symptoms. These disorders commonly have a genetic basis. The types of neoplasms themselves are not necessarily uncommon.


congenital disorder of glycosylation

Congenital disorder of glycosylation (CDG) is a fast growing group of inborn errors of metabolism characterized by defective activity of enzymes that participate in glycosylation (modification of proteins and other macromolecules by adding and processing of oligosaccharide side chains). CDG is comprised of phenotypically diverse disorders affecting multiple systems including the central nervous system, muscle function, immunity, endocrine system, and coagulation. The numerous entities in this group are subdivided, based on the synthetic pathway affected, into disorder of protein N-glycosylation, disorder of protein O-glycosylation, disorder of multiple glycosylation, and disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.


rotenones

Members of the class of rotenoid which consists of a 6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one skeleton and its substituted products.


glutathione S-transferase mu 2, initiator methionine removed form (human)

A glutathione S-transferase mu 2 (human) that has had the initiator methionine removed. UniProtKB:P28161, 2-218.


cancer-related nucleoside-triphosphatase isoform 1 (human)

A cancer-related nucleoside-triphosphatase isoform 1 that is encoded in the genome of human.


cytochrome b-245 heavy chain deaminated 1 (human)

A cytochrome b-245 heavy chain (human) that has been deaminated on the residue at the position equivalent to Asn-240 of the amino acid sequence represented by UniProtKB:P04839. UniProtKB:P04839, Asn-240, MOD:00684.


cytochrome b-245 heavy chain

A protein that is a translation product of the human CYBB gene or a 1:1 ortholog thereof.


cytochrome b-245 heavy chain isoform 1 (human)

A cytochrome b-245 heavy chain isoform 1 that is encoded in the genome of human.


cytochrome b-245 heavy chain, initiator methionine removed form (human)

A cytochrome b-245 heavy chain (human) that has had the initiator methionine removed. UniProtKB:P04839, 2-570.


cytochrome b-245 heavy chain cysteinylated 1 (human)

A cytochrome b-245 heavy chain (human) that has been cysteinylated on the residue at the position equivalent to Cys-257 of the amino acid sequence represented by UniProtKB:P04839. UniProtKB:P04839, Cys-257, MOD:00765.


protein mono-ADP-ribosyltransferase PARP14 methylated 2 (human)

A protein mono-ADP-ribosyltransferase PARP14 (human) that has been methylated on the residue at the position equivalent to Cys-1115 of the amino acid sequence represented by UniProtKB:Q460N5-6. Example: UniProtKB:Q460N5-6, Cys-1115, MOD:00660.


ATP-dependent RNA helicase DDX19A isoform h2 (human)

An ATP-dependent RNA helicase DDX19A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NUU7-2.


receptor tyrosine-protein kinase erbB-2 sequence variant R896C, signal peptide removed form (human)

A receptor tyrosine-protein kinase erbB-2 (human) that has a Cys residue at the position equivalent to Arg-896 of the amino acid sequence represented by UniProtKB:P04626-1 and that has had the signal peptide removed. Example: UniProtKB:P04626-1, 23-1255, Arg-896, CHEBI:29950.


exportin-2 isoform 1 (human)

An exportin-2 isoform 1 that is encoded in the genome of human.


voltage-dependent L-type calcium channel subunit alpha-1C isoform h37 (human)

A voltage-dependent L-type calcium channel subunit alpha-1C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13936-37.


dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B N-glycosylated 6 (human)

A dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (human) that has been N-glycosylated at the residue equivalent to Asn-627 of the amino acid sequence represented by UniProtKB:Q8TCJ2-1, in which the glycan composition is represented by GlyTouCan:G01650EU. Example: UniProtKB:Q8TCJ2-1, Asn-627, MOD:00160~GNO:G01650EU.


caveolae-associated protein 2

A protein that is a translation product of the human CAVIN2 gene or a 1:1 ortholog thereof.


ubiquitin carboxyl-terminal hydrolase 33 deaminated 1 (human)

A ubiquitin carboxyl-terminal hydrolase 33 (human) that has been deaminated on the residue at the position equivalent to Gln-255 of the amino acid sequence represented by UniProtKB:Q8TEY7-1. Example: UniProtKB:Q8TEY7-1, Gln-255, MOD:00685.


[F-actin]-monooxygenase MICAL2 isoform h7 (human)

An [F-actin]-monooxygenase MICAL2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O94851-7.


sodium/glucose cotransporter 2 sequence variant N654S (human)

A sodium/glucose cotransporter 2 (human) that has a Ser residue at the position equivalent to Asn-654 of the amino acid sequence represented by UniProtKB:P31639-1. Example: UniProtKB:P31639-1, Asn-654, CHEBI:29999.


E3 ubiquitin-protein ligase MARCHF8 isoform h1 (human)

An E3 ubiquitin-protein ligase MARCHF8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5T0T0-1.


eukaryotic translation initiation factor 5A-1 isoform 1 (human)

A eukaryotic translation initiation factor 5A-1 isoform 1 that is encoded in the genome of human.


diacylglycerol O-acyltransferase 2-like protein 6 deaminated 1 (human)

A diacylglycerol O-acyltransferase 2-like protein 6 (human) that has been deaminated on the residue at the position equivalent to Gln-214 of the amino acid sequence represented by UniProtKB:Q6ZPD8. UniProtKB:Q6ZPD8, Gln-214, MOD:00685.


diacylglycerol O-acyltransferase 2-like protein 6

A protein that is a translation product of the human DGAT2L6 gene or a 1:1 ortholog thereof.


serine/threonine-protein kinase 3

A protein that is a translation product of the human STK3 gene or a 1:1 ortholog thereof.


serine/threonine-protein kinase 3 deaminated 1 (human)

A serine/threonine-protein kinase 3 (human) that has been deaminated on the residue at the position equivalent to Asn-280 of the amino acid sequence represented by UniProtKB:Q13188-1. Example: UniProtKB:Q13188-1, Asn-280, MOD:00684.


serine/threonine-protein kinase 3 isoform h1 (human)

A serine/threonine-protein kinase 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13188-1.


serine/threonine-protein kinase 3 36kDa subunit (human)

A serine/threonine-protein kinase 3 36kDa subunit in human. Example: UniProtKB:Q13188-1, 1-322, Thr-180, MOD:00047.


serine/threonine-protein kinase 3 phosphorylated 2 (human)

A serine/threonine-protein kinase 3 (human) that has been phosphorylated on the residue at the position equivalent to Thr-180 of the amino acid sequence represented by UniProtKB:Q13188. UniProtKB:Q13188, Thr-180, MOD:00047.


serine/threonine-protein kinase 3 isoform h2 (human)

A serine/threonine-protein kinase 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13188-2.


serine/threonine-protein kinase 3 phosphorylated 1 (human)

A serine/threonine-protein kinase 3 (human) that has been phosphorylated on the residue at the position equivalent to Tyr-81 of the amino acid sequence represented by UniProtKB:Q13188-1. Example: UniProtKB:Q13188-1, Tyr-81, MOD:00048.


long-chain-fatty-acid--CoA ligase ACSBG2 isoform h2 (human)

A long-chain-fatty-acid--CoA ligase ACSBG2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5FVE4-2.


lysozyme-like protein 1 isoform h2 (human)

A lysozyme-like protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UWQ5-2.


parathyroid hormone-related protein isoform h3 (human)

A parathyroid hormone-related protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P12272-3.


catenin beta-1 isoform 1 phosphorylated 4 (human)

A catenin beta-1 isoform 1 phosphorylated 4 in human. UniProtKB:P35222-1, Ser-45, MOD:00046.


L-lactate dehydrogenase C chain, initiator methionine removed form (human)

An L-lactate dehydrogenase C chain (human) that has had the initiator methionine removed. UniProtKB:P07864, 2-332.


mitochondrial peptide methionine sulfoxide reductase isoform h2 (human)

A mitochondrial peptide methionine sulfoxide reductase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UJ68-2.


clathrin heavy chain 1 isoform 1 (human)

A clathrin heavy chain 1 isoform 1 that is encoded in the genome of human.


mothers against decapentaplegic homolog 3 sequence variant S425C (human)

A mothers against decapentaplegic homolog 3 (human) that has a Cys residue at the position equivalent to Ser-425 of the amino acid sequence represented by UniProtKB:P84022-1. Example: UniProtKB:P84022-1, Ser-425, CHEBI:29950.


aminopeptidase B isoform 1 (human)

An aminopeptidase B isoform 1 that is encoded in the genome of human.


tissue-type plasminogen activator N-glycosylated 68 (human)

A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G91905FJ. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G91905FJ.


E3 ubiquitin-protein ligase FANCL isoform 1 (human)

An E3 ubiquitin-protein ligase FANCL isoform 1 that is encoded in the genome of human.


phospholipid-transporting ATPase IK isoform h2 (human)

A phospholipid-transporting ATPase IK (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60423-1.


phospholipid-transporting ATPase IK cysteinylated 1 (human)

A phospholipid-transporting ATPase IK (human) that has been cysteinylated on the residue at the position equivalent to Cys-265 of the amino acid sequence represented by UniProtKB:O60423-2. Example: UniProtKB:O60423-2, Cys-265, MOD:00765.


phospholipid-transporting ATPase IK isoform h3 (human)

A phospholipid-transporting ATPase IK (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60423-3.


phospholipid-transporting ATPase IK isoform h1 (human)

A phospholipid-transporting ATPase IK (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60423-2.


Any member of the class of phenols that is phenol in which the hydrogens at positions 2 and 6 are substituted by a methoxy and an all-trans-polyprenyl group, respectively.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A

A protein that is a translation product of the human PDE1A gene or a 1:1 ortholog thereof.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h6 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-6.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h3 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-3.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h2 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-2.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A, initiator methionine removed form (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that has had the initiator methionine removed. UniProtKB:P54750, 2-535.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h7 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-7.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h5 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-5.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h1 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-1.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h8 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-8.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h9 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-9.


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform h4 (human)

A dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54750-4.


Grade 3 Colon Adenocarcinoma

A colon adenocarcinoma characterized by the presence of a malignant cellular infiltrate with less than 50% glandular formation.


sialin sequence variant H183R (human)

A sialin (human) that has an Arg residue at the position equivalent to His-183 of the amino acid sequence represented by UniProtKB:Q9NRA2-1. Example: UniProtKB:Q9NRA2-1, His-183, CHEBI:29952.


ubiquitin carboxyl-terminal hydrolase 51 methylated 1 (human)

A ubiquitin carboxyl-terminal hydrolase 51 (human) that has been methylated on the residue at the position equivalent to Cys-593 of the amino acid sequence represented by UniProtKB:Q70EK9. UniProtKB:Q70EK9, Cys-593, MOD:00660.


zinc-alpha-2-glycoprotein N-glycosylated 22 (human)

A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G03930BU. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G03930BU.


A 1,2-diacyl-sn-glycerol in which both acyl groups are specified as hexanoyl.


cell division cycle 7-related protein kinase isoform h1 (human)

A cell division cycle 7-related protein kinase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O00311-1.


ketohexokinase methylated 1 (human)

A ketohexokinase (human) that has been methylated on the residue at the position equivalent to Cys-282 of the amino acid sequence represented by UniProtKB:P50053-1. Example: UniProtKB:P50053-1, Cys-282, MOD:00660.


ketohexokinase isoform A (human)

A ketohexokinase isoform A that is encoded in the genome of human.


ketohexokinase isoform C (human)

A ketohexokinase isoform C that is encoded in the genome of human.


ketohexokinase sequence variant G40R (human)

A ketohexokinase (human) that has an Arg residue at the position equivalent to Gly-40 of the amino acid sequence represented by UniProtKB:P50053-1. Example: UniProtKB:P50053-1, Gly-40, CHEBI:29952.


ketohexokinase sequence variant A43T (human)

A ketohexokinase (human) that has a Thr residue at the position equivalent to Ala-43 of the amino acid sequence represented by UniProtKB:P50053-1. Example: UniProtKB:P50053-1, Ala-43, CHEBI:30013.


(S)-bopindolol

A 1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl benzoate that has S-configuration.


cytochrome b-c1 complex subunit Rieske, mitochondrial

A protein that is a translation product of the human UQCRFS1 gene or a 1:1 ortholog thereof.


cytochrome b-c1 complex subunit Rieske, mitochondrial, transit peptide removed form (human)

A cytochrome b-c1 complex subunit Rieske, mitochondrial (human) that has had the transit peptide removed. UniProtKB:P47985, 79-274.


cytochrome b-c1 complex subunit Rieske, mitochondrial isoform 1 (human)

A cytochrome b-c1 complex subunit Rieske, mitochondrial isoform 1 that is encoded in the genome of human.


cytochrome b-c1 complex Rieske-derived subunit 9 (human)

A cytochrome b-c1 complex Rieske-derived subunit 9 in human. UniProtKB:P47985, 1-78.


heparin cofactor 2 N-glycosylated 8 (human)

A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-49 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P05546-1, Asn-49, MOD:00160~GNO:G94917XT.


receptor-type tyrosine-protein phosphatase C isoform CD45RA (human)

A receptor-type tyrosine-protein phosphatase C isoform CD45RA that is encoded in the genome of human.


imidazobenzazepine

Any organic heterotricyclic compound that consists of an imidazole ring ortho-fused to a benzazepine.


The hydrochloride salt of chlorpromazine.


dibenzooxazepine

An organic heterotricyclic compound consisting of two benzene rings fused to a seven-membered ring containing one oxygen and one nitrogen atom.


organic heterotricyclic compound

An organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.


(R)-profenamine

The (R)-enantiomer of profenamine.


phenazines

Any  organonitrogen heterocyclic compound based on a phenazine skeleton and derivatives.


A 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one in which both stereocentres have R configuration.


fendosal

A benzoindole that is 4,5-dihydro-3H-benzo[e]indole in which the nitrogen is substituted by a 3-carboxy-4-hydroxyphenyl group. A non-narcotic analgesic and non-steroidal anti-inflammatory drug, it has greater analgesic and inflammatory responses than aspirin but with less gastrointestinal toxicity.


(S)-aceprometazine

The (S)-enantiomer of aceprometazine.


benzochromenone

A benzochromene in which the heterotricyclic ring system is substituted by an oxo group.


The 10H-tautomer of phenothiazine.


clopenthixol

A thioxanthene derivative having a chloro substituent at the 2-position and an alkylidene group at the 10-position with undefined double bond stereochemistry.


imidazobenzodiazepine

Any organic heterotricyclic compound that is any benzodiazepine which is ortho-fused with a imidazole.


psoralens

A furanocoumarin with a 7H-furo[3,2-g]chromen-7-one skeleton and its substituted derivatives thereof.


furanocoumarin

Any furochromene that consists of a furan ring fused with a coumarin. The fusion may occur in different ways in give several isomers.


(S)-etodolac

The S-enantiomer of etodolac. It is a preferential inhibitor of cyclo-oxygenase 2 and a non-steroidal anti-inflammatory, whereas the enantiomer, (R)-etodolac, is inactive. The racemate is commonly used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain.


nocamycin E

An organic heterotricyclic compound and tetramic acid derivative isolated from a mutant strain of Saccharothrix syringae. Nocamycin E exhibits considerably lower antibacterial activity than the corresponding methyl ester, nocamycin I.


(R)-carprofen

The (R)-(-)-enantomer of carprofen.


(S)-carprofen

The (S)-(+)-enantiomer of carprofen.


pyranobenzodioxin

Any organic heterotricyclic compound whose core skeleton consists of a benzodioxin ring that is ortho-fused to a pyran ring.


nocamycin I

An organic heterotricyclic compound and tetramic acid derivative originally isolated from an unidentified oligosporic actinomycete strain (no. E864-861) and found to be active against both Gram-positive and Gram-negative anaerobic bacteria as well as some aerobic bacteria such as Streptococci. The methyl ester of nocamycin E.


(R)-aceprometazine

The (R)-enantiomer of aceprometazine.


desmethyldoxepin

A dibenzooxepine resulting from the demethylation of the antidepressant doxepin. It is the active metabolite of doxepin.


cis-flupenthixol

A flupenthixol in which the double bond adopts a cis-configuration.


pyridochromene

An organic heterotricyclic compound composed of a pyridine ring fused to a chromene.


(R)-etodolac

The R-enantiomer of etodolac. It is inactive, in contrast to the enantiomer, (S)-etodolac, which is a preferential inhibitor of cyclo-oxygenase 2 and a non-steroidal anti-inflammatory. The racemate is commonly used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain.


A furanocoumarin which bears a hydroxy group at position 8.


A 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one in which both stereocentres have S configuration.


(E)-chlorprothixene

A chlorprothixene in which the double bond adopts an (E)-configuration.


Rhoduline Orange

Fluorescent dye useful for cell cycle determination. It is cell-permeable, and interacts with DNA and RNA by intercalation or electrostatic attractions respectively.


(Z)-chlorprothixene

A chlorprothixene in which the double bond adopts a (Z)-configuration.


benzoquinolizine

Any organic heterotricyclic compound with a skeleton consisting of a quinolizine fused to a benzene ring.


dipyridodiazepine

An organic heterotricyclic compound whose skeleton consists of a diazepine ring which is fused to two pyridine rings.


A furanocoumarin which bears a hydroxy group at position 5.


flavin

A derivative of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton, with a substituent on the 10 position.


pyridobenzodiazepine

Any three-ring heterocyclic compound with a skeleton consisting of a pyridine ring ortho-fused to a benzodiazepine.


(S)-profenamine

The (S)-enantiomer of profenamine.


triazolobenzodiazepine

Any organic heterotricyclic compound that is any benzodiazepine which is ortho-fused with a triazole.


An imidazoquinoline that is 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one which is substituted at positions 1, 3, and 8 by by p-(pyrrol-1-yl)phenyl, methyl, and pyridin-3-yl group, respectively. A potent and specific inhibitor of Target Of Rapamycin Complex 2 (TORC2).


thioxanthenes

Thioxanthene and its substitution derivatives.


nodakenetin

A marmesin with R-configuration.


oxazinoquinoline

Any organic heterotricyclic compound based on a skeleton comprised of an oxazine ring fused onto a quinoline system.


ATP-dependent DNA/RNA helicase DHX36 deaminated 2 (human)

An ATP-dependent DNA/RNA helicase DHX36 (human) that has been deaminated on the residue at the position equivalent to Asn-247 of the amino acid sequence represented by UniProtKB:Q9H2U1-1. Example: UniProtKB:Q9H2U1-1, Asn-247, MOD:00684.


ceramide synthase 6 isoform 1 (human)

A ceramide synthase 6 isoform 1 that is encoded in the genome of human.


fibronectin O-glycosylated 10 (human)

A fibronectin (human) that has been O-glycosylated at the residue equivalent to Thr-278 of the amino acid sequence represented by UniProtKB:P02751-15, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P02751-15, Thr-278, MOD:00005~GNO:G58001LT.


synaptotagmin-7 isoform r7 (rat)

A synaptotagmin-7 (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q62747-7.


transient receptor potential cation channel subfamily M member 2 isoform h2 (human)

A transient receptor potential cation channel subfamily M member 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O94759-2.


phosphatidylserine lipase ABHD16A isoform 1 (human)

A phosphatidylserine lipase ABHD16A isoform 1 that is encoded in the genome of human.


inborn organic aciduria

An inherited disorder that affects the metabolism of any acidic compound containing carbon in a covalent linkage.


3-methylcrotonyl-CoA carboxylase deficiency (3-MCCD) is an inherited disorder of leucine metabolism characterized by a highly variable clinical picture ranging from metabolic crisis in infancy to asymptomatic adults.


maple syrup urine disease type 1A

A maple syrup urine disease caused by mutations in BCKDHA.


thiamine-responsive maple syrup urine disease

Thiamine-responsive maple syrup urine disease (thiamine-responsive MSUD) is a less severe variant of MSUD that manifests with a phenotype similar to intermediate MSUD but that responds positively to treatment with thiamine.


inherited fatty acid metabolism disorder

A group of genetic disorders that result from the inability to produce or use an enzyme required to oxidize fatty acids, resulting in an inability to generate energy from fatty acid sources.


multiple carboxylase deficiency

Multiple carboxylase deficiency (MCD) is a term used to describe inborn errors of biotin metabolism characterized by reduced activities of biotin-dependent enzymes resulting in a wide spectrum of symptoms, including feeding difficulty, breathing difficulties, lethargy, seizures, skin rash, alopecia, and developmental delay.


methylmalonic aciduria and homocystinuria

An inborn error of vitamin B12 (cobalamin) metabolism characterized by megaloblastic anemia, lethargy, failure to thrive, developmental delay, intellectual deficit and seizures. There are four complementation classes of cobalamin defects (cblC, cblD, cblF and cblJ) that are responsible for methylmalonic acidemia - homocystinuria (methylmalonic acidemia - homocystinuria cblC, cblD cblF and cblJ).


disorder of fatty acid oxidation and ketogenesis


inherited lipoic acid biosynthesis defect

An inherited metabolic disease that is has its basis in the disruption of lipoate biosynthetic process.


vitamin B12-unresponsive methylmalonic acidemia type mut0

Vitamin B12-unresponsive methylmalonic acidemia type mut0 is an inborn error of metabolism characterized by recurrent ketoacidotic comas or transient vomiting, dehydration, hypotonia and intellectual deficit, which does not respond to administration of vitamin B12.


maple syrup urine disease type 1B

A maple syrup urine disease caused by mutations in BCKDHB.


intermediate maple syrup urine disease

Intermediate maple syrup urine disease (intermediate MSUD) is a milder form of MSUD characterized by persistently raised branched-chain amino acids (BCAAs) and ketoacids, but fewer or no acute episodes of decompensation.


intermittent maple syrup urine disease

Intermittent maple syrup urine disease (intermittent MSUD) is a mild form of MSUD where patients (when well) are asymptomatic with normal levels of branched-chain amino acids (BCAAs) but with catabolic stress are at risk of acute decompensation with ketoacidosis, which can lead to cerebral edema and coma if untreated.


classic maple syrup urine disease

Classic maple syrup urine disease (classic MSUD) is the most severe and probably common form of MSUD characterized by a maple syrup odor in the cerumen at birth, poor feeding, lethargy and focal dystonia, followed by progressive encephalopathy and central respiratory failure if untreated.


maple syrup urine disease type 2

A maple syrup urine disease caused by mutations in DBT.


vitamin B12-unresponsive methylmalonic acidemia type mut-

Vitamin B12-unresponsive methylmalonic acidemia type mut- is an inborn error of metabolism characterized by recurrent ketoacidotic comas or transient vomiting, dehydration, hypotonia and intellectual deficit, which does not respond to administration of vitamin B12.


vitamin B12-responsive methylmalonic acidemia

Vitamin B12-responsive methylmalonic acidemia (MA) is an inborn error of vitamin B12 (cobalamin) metabolism characterized by recurrent ketoacidotic comas or transient vomiting, dehydration, hypotonia and intellectual deficit, which responds to vitamin B12. There are three types: cblA, cblB and cblD-variant 2 (cblDv2).


An iminium salt composed of 4-{(4-anilinonaphthalen-1-yl)[4-(diethylamino)phenyl]methylidene}-N,N-diethylcyclohexa-2,5-dien-1-iminium and chloride ions in a 1:1 ratio.


cytochrome b deaminated 1 (human)

A cytochrome b (human) that has been deaminated on the residue at the position equivalent to Asn-85 of the amino acid sequence represented by UniProtKB:P00156. UniProtKB:P00156, Asn-85, MOD:00684.


phosphatidate cytidylyltransferase, mitochondrial acetylated 1 (human)

A phosphatidate cytidylyltransferase, mitochondrial (human) that has been acetylated on the residue at the position equivalent to Lys-206 of the amino acid sequence represented by UniProtKB:Q96BW9-1. Example: UniProtKB:Q96BW9-1, Lys-206, MOD:00723.


hydroxymethylglutaryl-CoA synthase, mitochondrial, transit peptide removed form (human)

A hydroxymethylglutaryl-CoA synthase, mitochondrial (human) that has had the transit peptide removed. UniProtKB:P54868, 38-508.


sodium/potassium-transporting ATPase subunit alpha-4 methylated 2 (human)

A sodium/potassium-transporting ATPase subunit alpha-4 (human) that has been methylated on the residue at the position equivalent to Glu-295 of the amino acid sequence represented by UniProtKB:Q13733-1. Example: UniProtKB:Q13733-1, Glu-295, MOD:00713.


frizzled-4 isoform 1 (human)

A frizzled-4 isoform 1 that is encoded in the genome of human.


synaptotagmin-like protein 2 isoform h3 (human)

A synaptotagmin-like protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9HCH5-4.


solute carrier family 22 member 6 isoform h1 (human)

A solute carrier family 22 member 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q4U2R8-1.


E3 ubiquitin-protein ligase RAD18 methylated 1 (human)

An E3 ubiquitin-protein ligase RAD18 (human) that has been methylated on the residue at the position equivalent to Asn-394 of the amino acid sequence represented by UniProtKB:Q9NS91. UniProtKB:Q9NS91, Asn-394, MOD:00673.


exocyst complex component 2 methylated 2 (human)

An exocyst complex component 2 (human) that has been methylated on the residue at the position equivalent to Cys-719 of the amino acid sequence represented by UniProtKB:Q96KP1. UniProtKB:Q96KP1, Cys-719, MOD:00660.


acyl-coenzyme A synthetase ACSM1, mitochondrial isoform h2 (human)

An acyl-coenzyme A synthetase ACSM1, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q08AH1-2.


galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 isoform 1 (human)

A galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 isoform 1 that is encoded in the genome of human.


gamma-aminooctyl-GTP

A nucleoside triphosphate analogue that is GTP in which one of the OH groups at the gamma-position of the triphosphate is replaced by an 8-aminooctylamino group.


G protein-activated inward rectifier potassium channel

An inwardly rectifying potassium channel protein that has core architecture consisting of an Inward rectifier potassium channel domain (Pfam:PF01007), which may be preceeded by an Inward rectifier potassium channel N-terminal domain (Pfam:PF08466).